DNPM – German Network for Personalised Medicine
The aim of the project is to establish Centres for Personalised Medicine at a further 13 locations nationwide and to bundle the competences in a German Network for Personalised Medicine (DNPM). In particular, the project partners will develop common standards and establish so-called „molecular tumour boards“ to provide patients with the best possible individualised treatment. A joint database will serve quality assurance and provide new insights for the further development of personalised medicine. The accompanying evaluation will examine in particular whether patients benefit directly from the new standards and structures and what challenges are associated with the establishment of corresponding centres. The Certification Commission of the German Cancer Society will develop requirements for the Centres for Personalised Medicine on the basis of which they will be certified.
Involved Institutions
Among others
Charité-Universitätsmedizin Berlin
Heinrich-Heine-Universität Düsseldorf
Klinikum der Universität München
Klinikum rechts der Isar
Technische Universität Dresden
Universität Ulm
Universitätsklinikum Aachen
Universitätsklinikum Bonn
Universitätsklinikum Essen
Universitätsklinikum Frankfurt
Universitätsklinikum Freiburg
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Heidelberg
Universitätsklinikum Köln
Universitätsklinikum Würzburg
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsklinikum Gießen und Marburg GmbH
Universitätsklinikum Münster
Medizinische Hochschule Hannover
Universitätsklinikum Göttingen
German Cancer Society (DKG)
Funding
Innovation Committee of The Federal Joint Committee (G-BA)
Duration
August 2021 – December 2024
Publications
see publications
Contact
PD Dr. Simone Wesselmann
